Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Biodegradable Sensor Helps Monitor Serious Health Conditions

By HospiMedica International staff writers
Posted on 29 Jan 2018
A new study describes how a biodegradable pressure sensor can monitor chronic lung disease, brain swelling, and other medical conditions before dissolving harmlessly in the body.

Under development at the University of Connecticut (UConn; Storrs, USA), the new sensor is made of two layers of piezoelectric poly-D,L-lactide (PDLLA) polymer film sandwiched between miniature molybdenum electrodes, and then encapsulated in layers of polylactic (PLA). More...
The piezoelectric PLLA film emits a small electrical charge when pressure is applied to it, allowing it to precisely measure pressures between 0–18 kPa, and maintain reliable performance levels for a period of up to four days in an aqueous environment.

In a proof of concept study, the researchers implanted the PLLA piezoelectric sensor in the abdominal cavity of a mouse in order to monitor the pressure of diaphragmatic contraction and respiratory rate. The implanted sensor was hardwired to an external signal amplifier, which transmitted the enhanced electrical signals to an oscilloscope. After four days, the sensor broke down into its individual organic components. Immune response was confined to minor inflammation in the surrounding tissues, which returned to normal after four weeks. The study was published on January 16, 2018, in Proceedings of the National Academy of Sciences (PNAS).

“We are very excited because this is the first time these biocompatible materials have been used in this way,” said senior author Thanh Duc Nguyen, PhD, of the UConn Institute of Materials Science. “Medical sensors are often implanted directly into soft tissues and organs. Taking them out can cause additional damage. We knew that if we could develop a sensor that didn't require surgery to take it out, that would be really significant.”

“There are many applications for this sensor. Let's say the sensor is implanted in the brain; we can use biodegradable wires and put the accompanying non-degradable electronics far away from the delicate brain tissue, such as under the skin behind the ear, similar to a cochlear implant,” concluded Dr. Nguyen. “Then it would just require a minor treatment to remove the electronics, without worrying about the sensor being in direct contact with soft brain tissue.”

Piezoelectricity, discovered in 1880 by French physicists Jacques and Pierre Curie, is a reversible effect in crystals that describes the internal generation of an electrical charge resulting from a mechanical force. For example, lead zirconate titanate crystals will generate measurable piezoelectricity when their static structure is deformed by about 0.1% of the original dimension. Conversely, those same crystals will change about 0.1% of their static dimension when an external electric field is applied to the material. The inverse piezoelectric effect is used in the production of ultrasonic sound waves.

Related Links:
University of Connecticut



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.